Bristol-Myers Squibb Co. makes unsolicited bid for ImClone

August 5th, 2008
| More
Bristol-Myers Squibb Co. made an unsolicited bid to buy ImClone Systems for $60/share or $4.5 billion. ImClone organized a committee to evaluate the bid but according to Chairman Carl Icahn, the bid `substantially undervalued' the company. Bristol-Myers currently owns 17% of ImClone's outstanding shares. ImClone has hinted that Bristol might have been privy to confidential information. According to ImClone, the board was recently discussing restructuring company into two businesses- one for Erbitrux, a $1.3 billion cancer drug franchise, and another for its promising drug development pipeline. John Celentano, a senior vice-president at Bristol-Myers, joined ImClone's board in May. While Mr. Celentano has an obligation to ImClone and representatives from Bristol have denied receiving any confidential information, there are still speculations about information being passed. Many analysts feel that a sale is on the horizon and that the back and forth between the two companies is the beginning of negotiations.
For Detailed Investor Profiles on these Investors, click below:
Icahn Associates (Carl Icahn)
Related People: Alexander J. Denner; Brett Icahn; Carl Icahn; Keith A. Meister*
Related Entities: High River Limited Partnership; Icahn Partners; Icahn & Co Inc; Icahn Associates; Icahn Enterprises (formerly American Real Estate Partners); Icahn Fund Ltd; Icahn Partners LP

More Recent Headlines

Hedge funds adopting “operational activism” approach

T. Boone Pickens sells off his Yahoo shares at a loss

Riley Investments wants Asyst Technology to sell itself

Riley Investments settles proxy battle with Transmeta corp

Sorin Capital gets talent from Capmark Investments

Citadel buys 5.3 percent of RadioShack stock

Hedge Fund BlueGold Capital makes huge returns on oil derivatives

Paulson & Co. plans troubled bank-focused fund launch

Seneca Capital and other Investors push TransAlt to merge

Icahn and two of his nominations added to Yahoo's board